Jiuping Ji
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 34
- PARP inhibition in cancer therapy 31
- CAR-T cell therapy research 2
-
- DNA Repair Mechanisms 21
- Cancer therapeutics and mechanisms 11
- Co-authors
- James H. DoroshowYves PommierYiping ZhangJunko MuraiShunichi TakedaAmèlie RenaudShar-yin N. HuangBenu Brata Das
- Journals
- Clinical Cancer Research (9 papers)PLoS ONE (4 papers)Cancer Research (4 papers)Molecular Cancer Therapeutics (3 papers)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Jiuping Ji
40 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 3.7k
- Reproductive Medicine 481
- Molecular Biology 3.2k
- Cancer Research 412
- Immunology 458
Countries citing papers authored by Jiuping Ji
This map shows the geographic impact of Jiuping Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiuping Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiuping Ji more than expected).
Fields of papers citing papers by Jiuping Ji
This network shows the impact of papers produced by Jiuping Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiuping Ji. The network helps show where Jiuping Ji may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiuping Ji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2020 | 22 | |
| 3 | 2017 | 50 | |
| 4 | 2017 | 4 | |
| 5 | 2017 | 73 | |
| 6 | 2016 | 38 | |
| 7 | 2016 | 6 | |
| 8 | 2016 | 64 | |
| 9 | 2015 | 255 | |
| 10 | 2014 | 206 | |
| 11 | 2014 | 145 | |
| 12 | Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib Hit paper breakdown → | 2013 | 592 |
| 13 | 2012 | 155 | |
| 14 | 2012 | 388 | |
| 15 | 2012 | 125 | |
| 16 | Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors Hit paper breakdown → | 2012 | 1613 |
| 17 | 2012 | 13 | |
| 18 | 2011 | 41 | |
| 19 | 2010 | 56 | |
| 20 | Abstract #5456: Correlation between inhibition of the activity of poly(ADP-ribose) polymerase (PARP) in human peripheral blood mononuclear cells (PBMCs) and tumor biopsies following treatment with ABT-888, an inhibitor of PARP | 2009 | 6 |
About Jiuping Ji
Jiuping Ji is a scholar working on Oncology, Molecular Biology, Statistics and Probability, Geriatrics and Gerontology and Genetics, having authored 41 papers that have together received 4.6k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (31 papers), DNA Repair Mechanisms (21 papers), Cancer therapeutics and mechanisms (11 papers), BRCA gene mutations in cancer (7 papers), Integrated Circuits and Semiconductor Failure Analysis (4 papers), Statistical Methods in Clinical Trials (3 papers), CAR-T cell therapy research (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Oncology (3.7k citations), Reproductive Medicine (481 citations), Molecular Biology (3.2k citations), Cancer Research (412 citations) and Immunology (458 citations). Jiuping Ji has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include James H. Doroshow, Yves Pommier, Yiping Zhang, Junko Murai, Shunichi Takeda, Amèlie Renaud, Shar-yin N. Huang, Benu Brata Das, Robert J. Kinders and Joel Morris. Their work appears in journals such as Clinical Cancer Research, PLoS ONE, Cancer Research, Molecular Cancer Therapeutics and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.